The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends for Over the Counter and Direct To Consumer: Forecasts by Application by Channel and by Country with Market Analysis and Executive Guides" has been added to ResearchAndMarkets.com's offering.

The evolution of Over the Counter (OTC) and Direct to Consumer (DTC) Diagnostics is poised to reestablish the dynamics of the diagnostic industry landscape. Emerging technologies are providing rapid test solutions specifically tailored for the home consumer market.

Genetic testing was the precursor, paving the way for the transition. Today, infectious disease testing is shifting its focus directly towards consumers. With advancements in sampling technology and the creation of rapid, multiplex tests, the traditional testing environment is transforming dramatically. The past pandemic underscored the critical need for self-testing capabilities, further propelling the trend. This report delves deep into the DTC outlook, revealing where the significant activities are occurring and highlighting key industry players.

Innovative technical advancements worldwide promise a vibrant and expanding market. Such progress suggests diagnostics will play a crucial role in the eradication of infectious diseases. Alongside the cutting-edge technologies already in use, the market is witnessing the introduction of even newer diagnostic tools.

The comprehensive report is packed with valuable insights, featuring an exhaustive list and analysis of the Current United States Medicare Fee Payment Schedules. These details are instrumental in refining strategic pricing models.

Catering to a global audience, the report meticulously breaks down the market landscape across 15 countries and 4 geographic regions. For stakeholders seeking in-depth, localized analysis, detailed country-specific insights are available upon purchasing the report.

A forward-looking perspective is provided with five-year market forecasts, allowing companies to strategize effectively and align their efforts with projected market trends.

Through embracing the consumer's desire for accessible diagnostics and facilitating easy-to-use solutions, the OTC and DTC market is set for substantial growth. This evolution not only empowers consumers but also opens new avenues for industry practitioners ready to lead in diagnostic innovation.

Key Topics Covered:

1 Market Guides

1.1 Situation Analysis

1.2 Guide for Executives and Marketing Staff

1.3 Guide for Investment Analysts and Management Consultants

2 Introduction and Market Definition

2.1 What is OTC and DTC Testing?

2.2 OTC/DTC Testing - the quiet revolution in diagnostics

2.3 Self vs. Send - who knew?

2.4 Market Definition

2.5 Methodology

2.6 Perspective: Healthcare and the IVD Industry

3 The Infectious Diseases - Guide to the Pathogens

3.1 Infections - The Big Picture

3.2 The Pathogens

3.2.1 Bacteria

3.2.2 Fungi and Protozoa

3.2.3 Viruses

3.2.4 Prions

3.2.5 Symptoms and Syndromes

3.2.6 Bacterial or viral

3.2.7 Typical Viral Symptoms

3.2.8 Typical Bacterial Symptoms

3.3 Disease

3.4 Transmission

3.5 Infectious Disease Diagnostics

3.5.1 Microbial culture

3.5.2 Microscopy

3.5.3 Biochemical tests

3.5.4 PCR-based diagnostics

3.5.5 Metagenomic sequencing

3.6 Defining Infections

3.7 Syndromic Infection

4 Industry Overview

4.1 Industry Participants

4.1.1 IVD Supplier

4.1.2 Independent lab specialized/esoteric

4.1.3 Independent lab national/regional

4.1.4 Independent lab analytical

4.1.5 Public National/regional lab

4.1.6 Hospital lab

4.1.7 Physician lab

4.1.8 Pharmacies

4.1.9 Audit body

4.2 The Clinical Laboratory Market Segments

4.2.1 Traditional Market Segmentation

4.2.2 Laboratory Focus and Segmentation

4.2.3 Segmenting the OTC/DTC Market

4.3 Industry Structure

4.3.1 Hospital Testing Share

4.3.2 Economies of Scale

4.3.3 Hospital vs. Central Lab

4.3.4 Physician Office Lab's

4.3.5 Physician's and OCT/DTC

4.3.6 Pharmacies and OCT/DTC

5 Market Trends

5.1 Factors Driving Growth

5.1.1 Privacy and Anonymity

5.1.2 The Internet Effect

5.1.3 Rapid Result

5.1.4 The Wellness Movement

5.1.5 The COVID-19 Impact

5.2 Factors Limiting Growth

5.2.1 Trust Factor

5.2.2 Infectious Disease is Declining But..

5.2.3 Wellness Hurts

5.2.4 Economic Growth improves Living Standards

5.3 Diagnostic Technology Development

5.3.1 The Multiplex Paradigm Shift

5.3.2 NAT vs. Lateral Flow

5.3.3 The Unusual Role of GPS

5.3.4 Self and Send Competition

5.3.5 The Relationship to DTC Genetic

5.3.6 The Relationship to TeleHealth

5.3.7 Sample Collection - Who Knew?

6 Recent Developments

6.1 Importance and How to Use This Section

6.1.1 Importance of These Developments

6.1.2 How to Use This Section

6.2 Silicon Valley Building Online Wellness Market

6.3 Simple HealthKit partners with Amazon

6.4 The future of at-home molecular testing

6.5 OTC Self-Tests, Tempered by Lack of Reimbursement

6.6 LetsGetChecked Gets FDA STD Test Approval

6.7 DiagMetrics Developing Breath Assays

6.8 Co-Diagnostics Awarded $2.3M for TB, HPV Tests

6.9 POC Developers Nuclein and Minute Molecular Dx Merge

6.10 ReadyGo Dx to Make MDx Testing a 'Snap'

6.11 Altratech Enters POC Space Supplanting PCR

6.12 FDA Authorizes First OTC Home Test for both Influenza and COVID-19

6.13 Pharmacies Poised to Capture At-Home Diagnostics Category

6.14 How Labcorp, Abbott, BD, Siemens plan to expand home testing market

6.15 Morgan Health Invests in LetsGetChecked

6.16 New US$ 1 price for HIV self-tests

6.17 Startup Detect to Roll Out Next-Gen Molecular Instrument

6.18 Diagnostics for the Real World Third-Generation POC Platform

6.19 Labcorp Partnering With Getlabs for Home Collection

6.20 Salignostics Closes Funding Round

6.21 Cue Health Targets DTC Market in 2022

6.22 Grip Molecular Developing Home Respiratory Panel

6.23 Mainz Biomed Developing Home ColoAlert Assay

6.24 MFB Fertility Closes Series A Financing Round

6.25 Continued Demand for SARS-CoV-2 Rapid Tests

6.26 Rapid COVID-19 Test Results Risk Going Uncounted

6.27 FDA Grants EUAs for Direct-to-Consumer Coronavirus Kit

6.28 Researchers Develop 15-Minute PCR System

6.29 Stanford Developing Low-Cost, At-Home, COVID-19 Saliva Test

6.30 Lucira Health Files for $115M IPO

6.31 Spectrum Solutions Gets CE Mark for Saliva Collection Devices

6.32 Sherlock Biosciences Receives Gates Foundation Grant for COVID-19 Self-Test

6.33 LabCorp Receives EUA for OTC COVID-19 Test Home Collection Kit

6.34 FemtoDx Launches Rapid At-Home Test Development for COVID-19

6.35 FDA approves first at-home coronavirus test

6.36 Free Home HIV Tests Detect More Infections

6.37 Biohacking trend supports self testing.

6.38 PerkinElmer and EverlyWell to Expand U.S. At-Home Health Test Market

6.39 Mylan, Atomo Diagnostics Get WHO Prequalification Approval for HIV Self-Test

6.40 OraSure Technologies, Inc. Announces Two Acquisitions

6.41 Nigerian Govt Approves Alere HIV Self-Test Kit

6.42 Boots launches UTI test and treat service across 37 branches

6.43 Scanwell Health moves beyond home UTI testing

6.44 Healthy.io raises $18 million for at-home urinalysis tests

6.45 LetsGetChecked collects $30M more for at-home health testing

6.46 TestCard, a $4 Urine Test Read by Smartphone

6.47 Digital Health Startup EverlyWell Raises $50M

6.48 Thriva adds test-at-home kits for female hormone and cortisol stress

6.49 Tasso scores $6.1M for patch-based home blood testing

6.50 DBS Systems HEMAXIS receives CE/IVD mark

6.51 Abbott HbA1c point-of-care test reliably diagnoses diabetes

7 Profiles of Key Diagnostic Testing Companies

7.1 1DropDiagnostics

7.2 Abbott Laboratories

7.3 Accel Diagnostics

7.4 Ador Diagnostics

7.5 ADT Biotech

7.6 Akonni Biosystems

7.7 AlphaBiolabs

7.8 Alveo Technologies

7.9 Applied BioCode

7.10 Atomo Diagnostics

7.11 Aureum Diagnostics

7.12 Aus Diagnostics

7.13 Becton, Dickinson and Company

7.14 Binx Health

7.15 Biocartis

7.16 BioFire Diagnostics (bioMerieux)

7.17 bioMerieux Diagnostics

7.18 Bio-Rad Laboratories, Inc

7.19 Bosch Healthcare Solutions GmbH

7.20 Cepheid (Danaher)

7.21 Cue Health

7.22 Curetis (OpGen)

7.23 DBS Systems

7.24 Detect

7.25 Diagenode Diagnostics (Hologic)

7.26 Diasorin S.p.A.

7.27 Domus Diagnostics

7.28 Ellume

7.29 Everywell

7.30 Getlabs

7.31 Grip Molecular Technologies

7.32 Healthy.io

7.33 Hologic

7.34 Inflammatix

7.35 Invetech

7.36 J&J Innovative Medicine

7.37 Karius

7.38 Laboratory Corporation of America

7.39 Letsgetchecked

7.40 LightDeck Diagnostics

7.41 Lucira Health (Pfizer)

7.42 LumiraDx

7.43 Meep

7.44 MFB Fertility

7.45 myLabBox

7.46 Nanomix

7.47 OraSure Technologies

7.48 Oxford Nanopore Technologies

7.49 Panagene

7.50 Prenetics

7.51 Primerdesign (Novacyt)

7.52 Prominex

7.53 Qiagen

7.54 QuantuMDx

7.55 Quest Diagnostics

7.56 QuidelOrtho

7.57 Randox Toxicology

7.58 R-Biopharm AG

7.59 Response Biomedical

7.60 Roche Diagnostics

7.61 Salignostics

7.62 SD Biosensor

7.63 Seegene

7.64 Sekisui Diagnostics

7.65 Siemens Healthineers

7.66 T2 Biosystems

7.67 TestCard

7.68 Thermo Fisher Scientific

7.69 Thriva

7.70 Visby Medical

7.71 XCR Diagnostics

7.72 YourBio Health

8 Global Market Size

8.1 OTC/DTC ID Global Market Size by Country

8.2 OTC/DTC ID Global Market Size by Syndrome

8.3 OTC/DTC ID Global Market Size by Channel

9 Global Market by Syndrome

9.1 Respiratory Market

9.2 STD Market

9.3 UTI Market

9.4 HxV Market

9.5 Other Market

10 Global Market by Channel

10.1 OTC Market

10.2 DTC Market

10.3 HSG Market

11 Appendices

11.1 Growth of Approved IVD Test Menu

11.2 Growth of Approved Average IVD Test Fee

11.3 The Most Used IVD Assays

11.4 The Highest Grossing Assays

11.5 Laboratory Fees Schedule

For more information about this report visit https://www.researchandmarkets.com/r/1i1ac5

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251119210177/en/